Home > Insider Trading > Filing (0001171843-14-004276)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
3116	Akorn Inc	AKRX	Pharmaceutical Preparations (2834)	720717400

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1466630	A Timothy Dick	1925 West Field Court Suite 300 Lake Forest IL 60045	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-09-05	40,010	$38.16	67,988	No	4	A	Direct
Common Stock	Acquisiton	2014-09-08	100,000	$1.00	167,988	No	4	M	Direct
Common Stock	Disposition	2014-09-08	45,000	$37.61	122,988	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2014-09-08	100,000	$0.00	100,000	$1.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2009-06-12	2019-06-12	No	4	M	Direct

Footnotes

The award was in the form of a grant of restricted shares, which will vest in four equal installments on September 5, 2015, September 5, 2016, September 5, 2017 and September 5, 2018.
Proceeds from the sale were used to pay exercise price and taxes due upon exercise of options.
Amount of Shares Beneficially Owned Following Reported Transaction includes 45,789 unvested shares subject to a restricted stock award and 77,199 shares owned outright.
There was no consideration given in exchange for the security.